Isosilybin B: a potential novel therapeutic agent with hepatoprotective, anticancer and antifibrotic properties
Obtained results suggest that isosilybin B represents a promising anticancer agent for the treatment of liver cancer. Moreover, its anti-fibrotic properties emphasize its potential for treatment of many other liver diseases, which underline the strong potential of isosilybin B in future anticancer and antifibrotic therapeutic strategies.
Authors
- Andrea Bábelová (ORCID: https://orcid.org/0000-0001-9548-6602)
- Michal Šelc (ORCID: https://orcid.org/0000-0002-7330-6655)
- Kristína Jakič (ORCID: https://orcid.org/0000-0002-8251-5328)
- Radka Macova (ORCID: https://orcid.org/0000-0002-3033-4648)
Institutions
- Slovak Academy of Sciences (SK)
- Cancer Research Institute of the Slovak Academy of Sciences (SK)
- Centre for Advanced Material Application of the Slovak Academy of Sciences (SK)
- Biomedical Research Center of the Slovak Academy of Sciences (SK)
- Comenius University Bratislava (SK)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1007/s12672-025-03380-8
- Primary Topic
- Silymarin and Mushroom Poisoning
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Slovenská Akadémia Vied
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV